insights_auto
Why is AMRN down 2.49%?
Dive Deeperchevron_right
AMRN:NASDAQ
Amarin Corporation PLC
$11.38
arrow_downward
-2.49%(-0.29) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$11.67
High
$11.68
Low
$11.33
Mkt. cap
240.38M
Avg. vol.
78.82K
Volume
36.79K
52-wk high
$17.31
52-wk low
$11.25
EPS
-$0.92
Beta
0.81
Shares outstanding
21.07M
No. of employees
80
Open
$11.67
High
$11.68
Low
$11.33
Mkt. cap
240.38M
Avg. vol.
78.82K
Volume
36.79K
52-wk high
$17.31
52-wk low
$11.25
EPS
-$0.92
Beta
0.81
Shares outstanding
21.07M
No. of employees
80
News stories
From web sources and news partners
Yahoo Finance
·
20 hours ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
CNBC
·
1 day ago
Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump
MarketWatch
·
12 hours ago
Stock Market on Nov. 13, 2026: Dow ends slightly higher, S&P 500 and Nasdaq fall as tech stocks struggle after Nvidia turmoil; U.S. equities market books weekly gain — live updates
Foreign Policy Journal
·
35 minutes ago
Centrus Energy (NYSE: LEU) Drops 45% In 90 Days Even As Meta-Backed Nuclear Contracts Roll In
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorHealth Care
IndustryBiotechnology
Websiteamarincorp.com